These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 13430709)

  • 21. The toxic effect of carbutamide (BZ 55) in diabetic dogs.
    SIREK A; SIREK OV; BEST CH
    Diabetes; 1957; 6(2):151-3. PubMed ID: 13427620
    [No Abstract]   [Full Text] [Related]  

  • 22. Metabolic effects of carbutamide in selected diabetics.
    BASTENIE PA; FRANCKSON JR; DE MEUTTER R; DEMANET TC; CONARD V
    Lancet; 1957 Mar; 272(6967):504-7. PubMed ID: 13407049
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of N1-sulphanylil-N2-n butylurea in diabetes mellitus].
    DI LORENZO S; MIOLA A
    Riforma Med; 1956 Jun; 70(22):619-23. PubMed ID: 13351267
    [No Abstract]   [Full Text] [Related]  

  • 24. Carbutamide and plasma insulin activity.
    VON HOLT C; VON HOLT L; KRACHT J; KRONER B; KUHNAU J
    Science; 1957 Apr; 125(3251):735-6. PubMed ID: 13421673
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of carbutamide on serum inorganic phosphate.
    DE VENANZI F
    Proc Soc Exp Biol Med; 1957 May; 95(1):33-4. PubMed ID: 13431978
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of carbutamide on serum-cholesterol level in diabetes mellitus.
    MUNRO IB; MURRAY D
    Lancet; 1956 Nov; 271(6952):1083-4. PubMed ID: 13377682
    [No Abstract]   [Full Text] [Related]  

  • 27. Occurrence of sensitivity and side reactions following carbutamide.
    KIRTLEY WR
    Diabetes; 1957; 6(1):72-3; discussion, 85-90. PubMed ID: 13397431
    [No Abstract]   [Full Text] [Related]  

  • 28. Compounds inhibiting insulin degradation.
    WILLIAMS RH
    Diabetes; 1957; 6(1):25-6; discussion, 30-2. PubMed ID: 13397415
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of carbutamide on the insulin content of the dog pancreas.
    ROOT MA
    Diabetes; 1957; 6(1):12-6; discussion, 19-20. PubMed ID: 13397411
    [No Abstract]   [Full Text] [Related]  

  • 30. Studies of the mechanism of action of sulfonylurea derivatives.
    GOLDNER MG; LAZARUS SS; VOLK BW; WEISENFELD S
    Diabetes; 1957; 6(1):53-4. PubMed ID: 13397423
    [No Abstract]   [Full Text] [Related]  

  • 31. Sulfonylureas and diabetes mellitus. I. Clinical evaluation.
    COX RW; FERGUS EB; HENLEY ED; WILLIAMS RH
    Diabetes; 1956; 5(5):358-65. PubMed ID: 13365475
    [No Abstract]   [Full Text] [Related]  

  • 32. A controlled trial of carbutamide in diabetic outpatients.
    DUNCAN GG; JOINER CL; LEE CT
    Diabetes; 1957; 6(1):83-4; discussion, 85-90. PubMed ID: 13397435
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of carbutamide in the diabetes associated with acromegaly.
    FEDERMAN DD; FIELD JB
    Diabetes; 1957; 6(1):70-2; discussion, 85-90. PubMed ID: 13397430
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of sulfonylurea drugs in hospitalized diabetic patients.
    RICKETTS HT; WILDBERGER HL
    Diabetes; 1957; 6(1):62-4; discussion, 85-90. PubMed ID: 13397427
    [No Abstract]   [Full Text] [Related]  

  • 35. Carbutamide in juvenile diabetes.
    BARTA L
    Lancet; 1957 May; 272(6978):1090. PubMed ID: 13429889
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical experience with carbutamide (BZ-55); a progress report.
    CAMERINI-DAVALOS R; MARBLE A; ROOT HF
    Diabetes; 1957; 6(1):74-7; discussion, 85-90. PubMed ID: 13397432
    [No Abstract]   [Full Text] [Related]  

  • 37. New experimental and clinical results with BZ-55 (carbutamide) in Germany.
    ACHELIS JD
    Diabetes; 1957; 6(1):40-1; discussion, 43-5. PubMed ID: 13397420
    [No Abstract]   [Full Text] [Related]  

  • 38. THIRD Lilly Conference on carbutamide; Indinapolis, Indiana, September 13-14, 1956.
    Diabetes; 1957; 6(1):1-94. PubMed ID: 13397408
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical studies on the hypoglycaemic action of the sulphonylureas.
    BUTTERFIELD WJ; CAMP JL; HARDWICK C; HOLLING HE
    Lancet; 1957 Apr; 272(6972):753-6. PubMed ID: 13417585
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical and pharmacological effects of substance BZ-55 in diabetes; (p-aminophenylsulfonyl butylcarbamide).
    ANDERSON RC; KIRTLEY WR; RIDOLFO AS; ROOT MA
    Diabetes; 1956; 5(5):351-7. PubMed ID: 13365474
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.